(Q34589789)

3 August 2017

Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors (English)

1 reference

3 August 2017

24

Kwok-Kin Wong

1 reference

3 August 2017

23

Matthew Meyerson

1 reference

3 August 2017

Hongbin Ji

1

1 reference

3 August 2017

Xiaojun Zhao

2

1 reference

3 August 2017

Yuki Yuza

3

1 reference

3 August 2017

Takeshi Shimamura

4

1 reference

3 August 2017

Danan Li

5

1 reference

3 August 2017

Alexei Protopopov

6

1 reference

3 August 2017

Boonim L Jung

7

1 reference

3 August 2017

Kate McNamara

8

1 reference

3 August 2017

Huili Xia

9

1 reference

3 August 2017

Karen A Glatt

10

1 reference

3 August 2017

Roman K Thomas

11

1 reference

3 August 2017

Hidefumi Sasaki

12

1 reference

3 August 2017

James W Horner

13

1 reference

3 August 2017

Michael Eck

14

1 reference

3 August 2017

Albert Mitchell

15

1 reference

3 August 2017

Yangping Sun

16

1 reference

3 August 2017

Ruqayyah Al-Hashem

17

1 reference

3 August 2017

Roderick T Bronson

18

1 reference

3 August 2017

Sridhar K Rabindran

19

1 reference

3 August 2017

Carolyn M Discafani

20

1 reference

3 August 2017

Elizabeth Maher

21

1 reference

3 August 2017

Geoffrey I Shapiro

22

1 reference

3 August 2017

language of work or name

English

0 references

publication date

3 May 2006

1 reference

Proceedings of the National Academy of Sciences of the United States of America

3 August 2017

1 reference

3 August 2017

103

1 reference

3 August 2017

7817-7822

1 reference

3 August 2017

20

1 reference

Erlotinib in lung cancer - molecular and clinical predictors of outcome

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

High-resolution genomic profiles of human lung cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

ERBB receptors and cancer: the complexity of targeted inhibitors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

The tumor-specific de2-7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Expression of constitutively activated EGFRvIII in non-small cell lung cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

ErbB-targeted therapeutic approaches in human cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Molecular pathogenesis of lung cancer and potential translational applications.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

The EGF receptor family as targets for cancer therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

EGF mutant receptor vIII as a molecular target in cancer therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Analysis of genomic rearrangements associated with EGRFvIII expression suggests involvement of Alu repeat elements

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Structural alterations of the epidermal growth factor receptor gene in human gliomas

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Immunohistochemical analysis of the mutant epidermal growth factor, deltaEGFR, in glioblastoma.

7 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0510284103

Conditional gene expression in the respiratory epithelium of the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0510284103

Conditional expression of fibroblast growth factor-7 in the developing and mature lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0510284103

Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0510284103

Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0510284103

The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456806

Space science. NASA backs two missions to spot promising planets

27 October 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0510284103

Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0510284103

Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16672372

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16672372

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.0510284103

1 reference

3 August 2017

0 references

1 reference

3 August 2017

1 reference